Equasens

Equities

EQS

FR0012882389

IT Services & Consulting

Market Closed - Euronext Paris 12:35:11 2024-03-18 pm EDT 5-day change 1st Jan Change
50.1 EUR +0.20% Intraday chart for Equasens -2.53% -18.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Equasens: annual sales growth of almost 3% CF
Equasens Société Anonyme Reports Consolidated Revenue Results for the Fourth Quarter and Full Year of 2023 CI
Global markets live: Airbus, Tesla, HSBC, KKR, Pfizer... Our Logo
Equasens to Acquire 70% Stake in Digipharmacie MT
Equasens: acquires 70% stake in Digipharmacie CF
Equasens Société anonyme acquired 70% stake in Digipharmacie. CI
Equasens: changes to the management committee CF
Equasens Group Announces Management Appointments, Effective 1 January 2024 CI
CAC40: up slightly, stalls at the 7300 pts mark CF
Equasens: share price up, broker confirms its recommendation CF
EQUASENS : Stifel maintains its recommendation on the share CF
Equasens: acquisition of German company ADV CF
Equasens, Arz Haan Buy German Pharmacy Software Group Apotheken Datenverarbeitung MT
Equasens Société anonyme and ARZ Haan AG acquired Ad Apotheken Datenverarbeitung Gmbh & Co. Kg. CI
EQUASENS : Stifel lowers its target price CF
Stifel Cuts Equasens PT, Affirms Hold Rating MT
EQUASENS : Stifel lowers its target price CF
Equasens: sales stable in Q3 CF
Equasens Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Equasens Société anonyme Reports Consolidated Sales Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Equasens Société Anonyme Provides Revenue Results for the First Quarter of 2023 CI
Global markets live: Bayer, ING, Merck, Sonos, Walt Disney.... Our Logo
Equasens Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Equasens Société anonyme acquired Atoopharm. CI
Global markets live: Tesla, McDonald's, Western Digital, Bed Bath & Beyond, Holcim... Our Logo
Chart Equasens
More charts
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
50.1 EUR
Average target price
71.55 EUR
Spread / Average Target
+42.81%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Equasens - Euronext Paris
  4. News Equasens
  5. PHARMAGEST INTERACTIVE : Sells Stake in Software Developer Unit to Private Healthcare Operator Elsan